Arcutis Biotherapeutics Inc.
ARQT | NASDAQ
$25.96
+$0.58 (+2.29%)
At close: Sep 21, 2026, 4:00 PM ET
$25.96
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $3.17B
Enterprise Value $3.12B
Beta 1.50
Average Volume 1.78M
Shares Outstanding (Diluted) 135.9M
Shares Change YoY 7.01%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US03969K1088
Price Performance
Price Change 1M 4.7%
Price Change 3M -1.2%
Price Change 6M 14.2%
Price Change YTD -10.5%
Price Change 1Y 49.4%
Price Change 3Y 382.5%
Price Change 5Y 12.0%
1M CAGR (ann.) -4.0%
1Y CAGR (ann.) 48.1%
5Y CAGR (ann.) 3.7%
All-Time CAGR 2.3%
Valuation
PE Ratio 123.62
Forward PE 17.17
PEG Ratio 0.02
Forward PEG 0.69
PS Ratio 7.00
Forward PS 4.70
PB Ratio 14.72
P/FCF Ratio 78.45
P/Adj. FCF Ratio -252.72
P/OCF Ratio 86.53
EV/Sales 6.73
EV/EBIT 75.83
EV/EBITDA 70.76
EV/FCF 75.45
Earnings Yield 0.8%
FCF Yield 1.3%
Adj. FCF Yield -0.4%
Financial Health
Net Cash $129.65M
Total Debt $114.14M
Cash & Short-Term Investments $238.55M
Total Assets $488.54M
Current Ratio 2.92
Quick Ratio 2.67
Debt / Equity Ratio 0.52
Debt / EBITDA 2.59
Debt / FCF 2.76
OCF / Debt 0.36
Interest Coverage 2.47
Altman Z-Score 5.84
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 91.1%
Operating Profit Margin 7.4%
EBITDA Margin 9.5%
Net Profit Margin 6.2%
FCF Margin 8.9%
Adj. FCF Margin -2.8%
SBC / Revenue 9.4%
SBC Impact (per share) -131.0%
Returns
Return on Assets 5.8%
Return on Equity 15.1%
Return on Invested Capital 9.9%
Return on Capital Employed 10.4%
Return on Tangible Assets 6.0%
Historical Growth (CAGR)
Revenue CAGR 3Y 241.4%
Revenue CAGR 5Y 67.7%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 131.9%
EPS CAGR 5Y 57.9%
EPS CAGR 10Y N/A
FCF CAGR 3Y 158.3%
FCF CAGR 5Y 51.1%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 12
EPS Growth Next 3Y 132.1%
Revenue Growth Next 3Y 27.6%
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number $2.83
Graham Upside -89.1%
Lynch Fair Value $5.25
Lynch Upside -79.8%
Price Target $38
Price Target Upside 46.4%
Cash Flow
Operating Cash Flow $41.55M
Free Cash Flow $41.39M
Adj. Free Cash Flow $-12.85M
FCF Per Share $0.30
OCF Per Share $0.30
OCF/S Ratio 8.5%
Income Statement
Revenue $463.98M
Gross Profit $422.89M
Operating Income $34.25M
EBITDA $44.13M
Net Income $28.52M
EPS (Diluted) $0.21
Revenue / Employee $1.31M
Profit / Employee $80.56K
Employees 354
Add to Watchlist
Select watchlists to add or remove ARQT